tiprankstipranks
Trending News
More News >
Star Health & Allied Insurance Co. Ltd. (IN:STARHEALTH)
:STARHEALTH
India Market
Advertisement

Star Health & Allied Insurance Co. Ltd. (STARHEALTH) AI Stock Analysis

Compare
2 Followers

Top Page

IN:STARHEALTH

Star Health & Allied Insurance Co. Ltd.

(STARHEALTH)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
₹565.00
▲(13.93% Upside)
Star Health & Allied Insurance Co. Ltd. demonstrates strong financial performance with consistent revenue growth and improved profitability, which is the most significant factor in its score. The technical analysis indicates a strong upward trend, though caution is advised due to overbought signals. The high P/E ratio suggests the stock is overvalued, which could limit future gains. The absence of earnings call data and corporate events means these factors do not influence the score.

Star Health & Allied Insurance Co. Ltd. (STARHEALTH) vs. iShares MSCI India ETF (INDA)

Star Health & Allied Insurance Co. Ltd. Business Overview & Revenue Model

Company DescriptionStar Health & Allied Insurance Co. Ltd. (STARHEALTH) is a prominent health insurance provider in India, specializing in offering a wide range of health insurance products and services. Established with the vision to provide affordable and accessible health coverage, the company caters to individual customers, families, and corporate clients. STARHEALTH's core offerings include health insurance policies, critical illness plans, personal accident covers, and specialized insurance products tailored for senior citizens and maternity needs. The company focuses on enhancing customer experience through innovative solutions and a robust network of healthcare providers.
How the Company Makes MoneyStar Health & Allied Insurance Co. Ltd. generates revenue primarily through the sale of insurance premiums collected from policyholders. The company offers a variety of health insurance products, and the premiums collected form a significant portion of its income. Additionally, STARHEALTH earns money through investment income generated by investing the premiums in various financial instruments, such as stocks, bonds, and mutual funds. The company also benefits from partnerships with healthcare providers and hospitals, which may lead to increased customer acquisition and retention. Furthermore, STARHEALTH may leverage regulatory incentives and government health initiatives to expand its reach and enhance profitability.

Star Health & Allied Insurance Co. Ltd. Financial Statement Overview

Summary
Star Health & Allied Insurance Co. Ltd. presents a strong financial position with consistent revenue growth and improving profitability metrics. The company has successfully reduced leverage, enhanced equity returns, and maintained solid cash flows, indicating financial stability and operational efficiency. While past challenges were evident in initial years, the recent improvements signal a positive trajectory for future performance.
Income Statement
75
Positive
Star Health & Allied Insurance Co. Ltd. has demonstrated a solid growth trajectory with Total Revenue increasing consistently over the years, from 2020 to 2025. The Gross Profit Margin remains strong at 100% consistently, indicating excellent cost management. Net Profit Margin has improved significantly from negative in 2021 to positive 4.01% in 2025, showcasing a successful turnaround. The EBIT and EBITDA margins have also improved, reflecting better operational efficiency. However, the initial years saw negative EBIT and EBITDA, indicating past challenges.
Balance Sheet
70
Positive
The company maintains a healthy Debt-to-Equity Ratio, declining from 0.15 in 2020 to 0.07 in 2025, demonstrating reduced leverage and improved financial stability. The Return on Equity has turned positive in recent years, reaching 9.08% in 2025, indicating effective use of shareholder capital. The Equity Ratio remains strong, showcasing a stable financial structure. However, initial high leverage in past years posed risks.
Cash Flow
80
Positive
Star Health has shown robust cash flow management with Operating Cash Flow consistently exceeding Net Income, indicating strong cash-generating abilities. The Free Cash Flow has exhibited growth, reflecting efficient capital expenditure management. The Operating Cash Flow to Net Income Ratio is stable, supporting a strong liquidity position. However, fluctuations in cash from investing activities in earlier years hint at past challenges.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue169.05B164.88B144.13B122.41B106.02B57.75B
Gross Profit141.49B138.61B121.61B104.13B91.10B44.64B
EBITDA7.87B9.98B12.68B9.67B-13.05B-13.72B
Net Income5.89B6.46B8.45B6.19B-10.41B-10.86B
Balance Sheet
Total Assets209.38B207.85B180.54B163.58B152.79B112.26B
Cash, Cash Equivalents and Short-Term Investments0.006.58B13.68B10.49B12.11B21.02B
Total Debt4.70B4.70B4.70B4.70B7.20B2.50B
Total Liabilities132.71B136.72B113.23B97.69B88.83B70.09B
Stockholders Equity76.67B71.12B67.32B65.89B63.96B42.17B
Cash Flow
Free Cash Flow0.0012.96B11.86B12.29B-340.86M8.19B
Operating Cash Flow0.0013.79B13.10B12.76B290.43M8.65B
Investing Cash Flow0.00-11.51B-11.77B-10.97B-37.86B-24.18B
Financing Cash Flow0.00-42.00M229.73M-2.68B25.36B26.39B

Star Health & Allied Insurance Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price495.90
Price Trends
50DMA
478.70
Positive
100DMA
457.58
Positive
200DMA
429.85
Positive
Market Momentum
MACD
6.14
Positive
RSI
51.62
Neutral
STOCH
24.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:STARHEALTH, the sentiment is Neutral. The current price of 495.9 is below the 20-day moving average (MA) of 496.79, above the 50-day MA of 478.70, and above the 200-day MA of 429.85, indicating a neutral trend. The MACD of 6.14 indicates Positive momentum. The RSI at 51.62 is Neutral, neither overbought nor oversold. The STOCH value of 24.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:STARHEALTH.

Star Health & Allied Insurance Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Neutral
₹85.67B24.360.42%14.80%1.35%
67
Neutral
₹107.77B287.3517.58%-38.20%
66
Neutral
₹287.26B53.8628.04%-38.44%
65
Neutral
₹335.69B62.800.04%15.78%15.01%
60
Neutral
₹177.69B28.011.22%11.42%-1.91%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:STARHEALTH
Star Health & Allied Insurance Co. Ltd.
495.90
37.50
8.18%
IN:APLLTD
Alembic Pharmaceuticals Limited
905.00
-185.76
-17.03%
IN:HCG
HealthCare Global Enterprises Ltd.
725.85
250.15
52.59%
IN:MARKSANS
Marksans Pharma Limited
188.75
-147.56
-43.88%
IN:MEDANTA
Global Health Limited
1,250.95
148.75
13.50%
IN:MEDIASSIST
Medi Assist Healthcare Services Limited
482.70
-102.35
-17.49%

Star Health & Allied Insurance Co. Ltd. Corporate Events

Star Health Insurance’s Rating Affirmed at ‘IND AA+’ with Stable Outlook
Oct 4, 2025

Star Health and Allied Insurance Company Limited has had its rating affirmed at ‘IND AA+’ with a stable outlook by India Ratings and Research, highlighting its strong market leadership, robust underwriting practices, and differentiated operating model. The company maintains a 33% share of the retail health insurance market in India and reported a gross written premium of ₹16,781 crore for FY25. With a solvency ratio of 2.21x, Star Health’s financial resilience is supported by its operational model, which includes a large team of in-house doctors and efficient claims processing systems. The reaffirmation underscores Star Health’s role as a trusted partner in India’s healthcare ecosystem and its commitment to expanding access to quality healthcare protection.

Star Health & Allied Insurance Holds 20th AGM Virtually
Sep 23, 2025

Star Health & Allied Insurance Co. Ltd. conducted its 20th Annual General Meeting (AGM) on September 23, 2025, through video conferencing. The meeting was chaired by Mr. Rajeev Kher, with the presence of key management personnel, board members, and auditors. The AGM adhered to regulatory guidelines and allowed members to inspect statutory registers electronically. The meeting facilitated discussions on the company’s operations and future strategies, with speeches from the Chairperson and the Managing Director & CEO.

Star Health & Allied Insurance Announces Postal Ballot Results
Sep 1, 2025

Star Health & Allied Insurance Co. Ltd. announced the results of its postal ballot, which sought member approval for business matters through an e-voting process. The scrutinizer’s report, prepared by M/s Irshad and Associates, confirmed the completion of the voting process in compliance with relevant regulations, ensuring transparency and fairness. This announcement underscores the company’s commitment to regulatory compliance and stakeholder engagement, potentially enhancing its reputation and operational transparency.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 15, 2025